Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 48Neoplasm Metastasis 11Hereditary Sensory and Autonomic Neuropathies 7Squamous Cell Carcinoma of Head and Neck 5Recurrence 5Ovarian Neoplasms 5Neoplasms 5Triple Negative Breast Neoplasms 3Multiple Endocrine Neoplasia Type 1 3Lymphangioma 3Hyperglycemia 3Head and Neck Neoplasms 3Pancreatic Neoplasms 2Melanoma 2Lymphatic Abnormalities 2Lymphangioma, Cystic 2Head and Neck Squamous Cell Cancer 2Endometrial Neoplasms 2Colorectal Neoplasms 2Advanced Breast Cancer 2Vascular Malformations 1Uveal Melanoma 1Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein 1Stomach Neoplasms 1Solid Tumor 1Skin Diseases, Vascular 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Pre-menopausal Breast Cancer 1

Interventions

Paclitaxel 11Carboplatin 8Radiotherapy 7Letrozole 7Cyclophosphamide 7Trastuzumab 5Chemotherapy, Adjuvant 5Doxorubicin 4Brachytherapy 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4atamestane 3Toremifene 3Tamoxifen 3Radiotherapy, Conformal 3Magnetic Resonance Spectroscopy 3Epirubicin 3Docetaxel 3Cryosurgery 3Cisplatin 3pertuzumab 2Surgical Procedures, Operative 2Radiation 2Lapatinib 2Fulvestrant 2Estrogen Receptor Modulators 2Cryotherapy 2Capecitabine 2Biopsy 2Aromatase Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ductal, Breast × Alpelisib × Clear all
NCT01791478 2024-07-23

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Vanderbilt-Ingram Cancer Center

Phase 1 Active not recruiting
46 enrolled
Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon âš¡